Rybelsus 7 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7UZ2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,947
Award facts
- Contract value 100% obligated
- $12,947.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,947.18 by the Defense Logistics Agency (DLA) on January 7, 2026, for the supply of Rybelsus 7 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, an agreement valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor within the federal medical supply chain, particularly supporting military healthcare systems and the Defense Health Agency. The company's substantial IDC with DLA enables it to supply a comprehensive range of pharmaceutical products and medical supplies globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen competes on a full and open basis for these awards, demonstrating consistent capability in fulfilling federal procurement requirements across multiple therapeutic domains including diabetes management medications such as Rybelsus.
Quick answers
Who was awarded contract SPE2DR26F7UZ2?
SPE2DR26F7UZ2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F7UZ2 worth?
The government has obligated $12,947 on SPE2DR26F7UZ2.
Is contract SPE2DR26F7UZ2 an order under another contract?
Yes. SPE2DR26F7UZ2 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UZ2 competed?
The extent of competition for SPE2DR26F7UZ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award